- Home
- RFIL vs VYNE Comparison
RFIL vs VYNE Comparison
Compare RFIL & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- VYNE
- Stock Information
- Founded
- RFIL 1979
- VYNE 2003
- Country
- RFIL United States
- VYNE United States
- Employees
- RFIL N/A
- VYNE N/A
- Industry
- RFIL Electrical Products
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- RFIL Technology
- VYNE Health Care
- Exchange
- RFIL Nasdaq
- VYNE Nasdaq
- Market Cap
- RFIL 35.8M
- VYNE 38.2M
- IPO Year
- RFIL N/A
- VYNE 2018
- Fundamental
- Price
- RFIL $3.82
- VYNE $1.90
- Analyst Decision
- RFIL Strong Buy
- VYNE Strong Buy
- Analyst Count
- RFIL 1
- VYNE 1
- Target Price
- RFIL $4.00
- VYNE $5.75
- AVG Volume (30 Days)
- RFIL 7.3K
- VYNE 40.5K
- Earning Date
- RFIL 09-16-2024
- VYNE 08-14-2024
- Dividend Yield
- RFIL N/A
- VYNE N/A
- EPS Growth
- RFIL N/A
- VYNE N/A
- EPS
- RFIL N/A
- VYNE N/A
- Revenue
- RFIL $61,094,000.00
- VYNE $486,000.00
- Revenue This Year
- RFIL N/A
- VYNE $32.31
- Revenue Next Year
- RFIL $8.33
- VYNE N/A
- P/E Ratio
- RFIL N/A
- VYNE N/A
- Revenue Growth
- RFIL N/A
- VYNE 19.41
- 52 Week Low
- RFIL $2.51
- VYNE $1.57
- 52 Week High
- RFIL $4.65
- VYNE $4.48
- Technical
- Relative Strength Index (RSI)
- RFIL 53.88
- VYNE 53.49
- Support Level
- RFIL $3.36
- VYNE $1.77
- Resistance Level
- RFIL $3.85
- VYNE $1.98
- Average True Range (ATR)
- RFIL 0.15
- VYNE 0.10
- MACD
- RFIL 0.02
- VYNE 0.02
- Stochastic Oscillator
- RFIL 75.81
- VYNE 51.61
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.